2.25
price down icon0.88%   -0.02
 
loading
Precedente Chiudi:
$2.27
Aprire:
$2.26
Volume 24 ore:
334.87K
Relative Volume:
0.39
Capitalizzazione di mercato:
$239.44M
Reddito:
$45.44M
Utile/perdita netta:
$-35.43M
Rapporto P/E:
-6.6176
EPS:
-0.34
Flusso di cassa netto:
$-25.39M
1 W Prestazione:
+11.39%
1M Prestazione:
+0.90%
6M Prestazione:
-51.72%
1 anno Prestazione:
-51.30%
Intervallo 1D:
Value
$2.18
$2.27
Intervallo di 1 settimana:
Value
$2.02
$2.37
Portata 52W:
Value
$2.00
$5.20

Maxcyte Inc Stock (MXCT) Company Profile

Name
Nome
Maxcyte Inc
Name
Telefono
301-517-5556
Name
Indirizzo
9713 KEY WEST AVENUE,, ROCKVILLE
Name
Dipendente
114
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
MXCT's Discussions on Twitter

Confronta MXCT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
MXCT
Maxcyte Inc
2.25 241.34M 45.44M -35.43M -25.39M -0.34
Medical Devices icon
ABT
Abbott Laboratories
126.54 218.59B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.14 157.13B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
403.53 151.59B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.94 118.29B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
80.00 44.46B 5.54B 4.18B 623.10M 7.00

Maxcyte Inc Stock (MXCT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-22 Iniziato Stephens Overweight
2023-11-29 Iniziato Craig Hallum Buy
2021-10-15 Ripresa Cowen Outperform
2021-08-24 Iniziato BTIG Research Buy
2021-08-24 Iniziato Cowen Outperform
2021-08-24 Iniziato Stephens Overweight
2021-08-24 Iniziato Stifel Buy
2021-08-24 Iniziato Wedbush Outperform
2021-08-24 Iniziato William Blair Outperform
Mostra tutto

Maxcyte Inc Borsa (MXCT) Ultime notizie

pulisher
Jul 25, 2025

What drives MaxCyte Inc. stock priceHigh-yield investments - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What makes MaxCyte Inc. stock attractive to long term investorsRapid growth trajectories - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

How MaxCyte Inc. stock performs during market volatilitySmart Growth Low Risk Picks - Newser

Jul 25, 2025
pulisher
Jul 24, 2025

Is MaxCyte Inc. a good long term investmentHigh-return market picks - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about MaxCyte Inc. stockRapid portfolio appreciation - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

MaxCyte Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Published on: 2025-07-23 21:52:41 - Autocar Professional

Jul 23, 2025
pulisher
Jul 15, 2025

Why MaxCyte Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes MaxCyte Inc. stock price move sharplySwing Trade Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

IWN ETF Implied Analyst Target Price: $198.15 - AInvest

Jul 15, 2025
pulisher
Jul 11, 2025

MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - 富途牛牛

Jul 11, 2025
pulisher
Jul 09, 2025

MaxCyte, Inc. to Release Second Quarter 2025 Financial Results on August 6th - Nasdaq

Jul 09, 2025
pulisher
Jul 02, 2025

PHC announces exclusive distribution of MaxCyte ExPERT platform in Japan - BioSpectrum Asia

Jul 02, 2025
pulisher
Jul 01, 2025

PHC TO EXCLUSIVELY DISTRIBUTE MAXCYTE CELL ENGINEERING PLATFORM IN JAPAN - bernama

Jul 01, 2025
pulisher
Jul 01, 2025

Business Wire - JIJI PRESS

Jul 01, 2025
pulisher
Jul 01, 2025

PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan - Business Wire

Jul 01, 2025
pulisher
Jun 26, 2025

MaxCyte Cancels AIM Market Trading for Common Stock - TipRanks

Jun 26, 2025
pulisher
Jun 25, 2025

MaxCyte to delist shares from London AIM, maintains Nasdaq listing - Investing.com

Jun 25, 2025
pulisher
Jun 23, 2025

Moving Gene Editing Advances Into the Clinic - the-scientist.com

Jun 23, 2025
pulisher
Jun 19, 2025

MaxCyte stockholders approve AIM delisting, company to trade only on Nasdaq - Investing.com

Jun 19, 2025
pulisher
Jun 18, 2025

MaxCyte Shareholders Approve Equity Plan Amendment - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

MaxCyte shareholders approve equity plan expansion, AIM delisting - Investing.com

Jun 18, 2025

Maxcyte Inc Azioni (MXCT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Maxcyte Inc Azioni (MXCT) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Soleymannezhad Ali
Chief Commercial Officer
Mar 18 '25
Sale
3.18
1,211
3,850
59,439
Sandoval David I.
GENERAL COUNSEL
Mar 18 '25
Sale
3.18
353
1,122
64,219
Swirsky Douglas J
CHIEF FINANCIAL OFFICER
Mar 18 '25
Sale
3.18
6,939
22,061
111,811
Johnston John Joseph
Director
Jan 27 '25
Option Exercise
2.93
3,000
8,796
144,950
Johnston John Joseph
Director
Jan 27 '25
Sale
4.64
3,000
13,935
141,950
Sandoval David I.
GENERAL COUNSEL
Jan 13 '25
Sale
4.54
4,466
20,272
41,447
Johnston John Joseph
Director
Dec 26 '24
Option Exercise
2.93
3,000
8,796
144,950
Johnston John Joseph
Director
Dec 26 '24
Sale
4.01
3,000
12,021
141,950
$290.22
price up icon 1.27%
medical_devices STE
$230.46
price up icon 1.41%
medical_devices PHG
$26.16
price up icon 1.24%
$88.99
price up icon 2.59%
$77.61
price up icon 1.09%
medical_devices EW
$80.00
price up icon 5.54%
Capitalizzazione:     |  Volume (24 ore):